EMBO welcomes 28 new Young Investigators
Heidelberg, 25 October 2017 – EMBO announces today the selection of 28 young researchers as EMBO Young Investigators. They join a network of 47 current and 417 past Young Investigators who represent some of the best up-and-coming group leaders in the life sciences in Europe and beyond.
“It is a pleasure to welcome these outstanding scientists to the EMBO community,” says EMBO Director Maria Leptin. “Between them, they carry out some of the most promising life science research that Europe has to offer, and we look forward to supporting them in their professional and scientific undertakings.”
The new Young Investigators are based in 11 different countries, including two European Molecular Biology Conference (EMBC) Associate Member States, India and Singapore.
Selection to the EMBO Young Investigator Programme is recognition of exceptional research and scientific potential. Through the programme, EMBO identifies and supports some of the best researchers under 40 years of age who are in the process of establishing their own laboratory.
During their three-year tenure, EMBO Young Investigators receive a range of benefits, including an award of 15,000 euros and possible additional funds to support the establishment of their first independent laboratories.
Laboratory management and non-scientific skills training as well as PhD courses offer the young group leaders and their students the chance to develop professional skills. The scientists also receive access to core facilities at the European Molecular Biology Laboratory in Heidelberg, Germany, and funding for themselves and their group members to attend conferences.
The next application deadline is 1 April 2018. More information is available at http://www.embo.org/funding-awards/young-investigators
Selected statistics about the EMBO Young Investigators 2017
- the programme received 224 eligible applications
- with 12.5%, the application success rate was comparable to previous years
- 39% of new Young Investigators are women
- newly elected Young Investigators reside in 11 countries
EMBO Young Investigator |
Research interest |
Institute |
Location |
Filipe Cabreiro |
Bacteria: macromolecular machines for nutrition and drugs |
University College London; Birkbeck University |
London, GB |
Jeffrey Chao |
Imaging mRNAs in single cells |
Friedrich Miescher Institute for Biomedical Research |
Basel, CH |
Luisa Cochella |
Transcriptional and post-transcriptional origins of cellular diversity |
Research Institute of Molecular Pathology (IMP), Vienna BioCenter |
Vienna, AT |
Katie Doores |
Glycosylation in infectious diseases |
King's College London |
London, GB |
Luca Giorgetti |
Mechanisms of long-range transcriptional regulation |
Friedrich Miescher Institute for Biomedical Research |
Basel, CH |
Axel Innis |
Ribosome inhibition by nascent or antimicrobial peptides |
French National Institute of Health and Medical Research (INSERM) |
Bordeaux, FR |
Nicola Iovino |
Epigenetic regulation of fertilization |
Max Planck Institute of Immunobiology and Epigenetics |
Freiburg, DE |
Manuel Irimia |
Transcriptomics of vertebrate development and evolution |
Centre for Genomic Regulation |
Barcelona, ES |
Sonja Lorenz |
Structural mechanisms of ubiquitin signaling |
University of Wuerzburg |
Wuerzburg, DE |
Dahai Luo |
Mechanisms of viral infection and host defense |
Lee Kong Chian School of Medicine, Nanyang Technological University |
Singapore, SG |
Joao Matos |
Mechanisms of genome stability and haploidisation |
ETH Zurich |
Zurich, CH |
Daniel Messerschmidt |
Epigenetic reprogramming and its implications in development and disease |
Institute of Molecular and Cell Biology |
Singapore, SG |
Patrick Müller |
Quantitative analysis, control, and engineering of embryonic signalling systems |
Friedrich Miescher Laboratory of the Max Planck Society |
Tübingen, DE |
Elizabeth Murchison |
Genetics and evolution of transmissible cancers in dogs and Tasmanian devils |
University of Cambridge |
Cambridge, GB |
Vladimir Pena |
Structural basis of splicing regulation and DNA-based catalysis |
Max Planck Institute for Biophysical Chemistry |
Goettingen, DE |
Hendrik Poeck |
Cytosolic nucleic acid sensors in tissue homeostasis and cancer immunotherapy |
Klinikum Rechts der Isar, Technical University of Munich |
Munich, DE |
Sophie Polo |
Epigenome maintenance in response to DNA damage |
CNRS; Paris Diderot University |
Paris, FR |
Magdalini Polymenidou |
Molecular pathogenesis of neurodegenerative diseases |
University of Zurich |
Zurich, CH |
Alvaro Rada-Iglesias |
Transcriptional regulation in development and congenital disease |
Center for Molecular Medicine Cologne, University of Cologne |
Cologne, DE |
Guadalupe Sabio |
p38MAPK signalling pathway |
Spanish National Center for Cardiovascular Research (CNIC) |
Madrid, ES |
Schraga Schwartz |
Cracking the epitranscriptome |
Weizmann Institute of Science |
Rehovot, IL |
Elena Seiradake |
Adhesion G protein-coupled receptor complexes |
University of Oxford |
Oxford, GB |
Arun Shukla |
Structure, function and allosteric modulation of G protein-coupled receptors |
Indian Institute of Technology Kanpur |
Kanpur, IN |
Noam Stern-Ginossar |
Molecular networks of viral-host interaction |
Weizmann Institute of Science |
Rehovot, IL |
Joanna Sulkowska |
SPOUT methyltransferase enzymes |
University of Warsaw |
Warsaw, PL |
Dario Riccardo Valenzano |
Evolutionary and experimental biology of ageing |
Max Planck Institute for Biology of Ageing |
Cologne, DE |
Louis Vermeulen |
Colon cancer heterogeneity |
Academic Medical Center |
Amsterdam, NL |
Yue Wan |
RNA structure and genomics |
Genome Institute of Singapore |
Singapore, SG |